Solicitation of Nominations for Membership on the Advisory Committee on Blood Safety and Availability, 20292-20293 [E8-7986]
Download as PDF
<![CDATA[
20292
Federal Register / Vol. 73, No. 73 / Tuesday, April 15, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Membership on the Advisory
Committee on Blood Safety and
Availability
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
AGENCY:
SUMMARY: The Office of Public Health
and Science (OPHS) is seeking
nominations of qualified individuals to
be considered for appointment as
members of the Advisory Committee on
Blood Safety and Availability (ACBSA).
ACBSA is a Federal advisory committee
in the Department of Health and Human
Services. Management support for the
activities of this Committee is the
responsibility of the OPHS.
The qualified individuals will be
nominated to the Secretary of Health
and Human Services for consideration
of appointment as members of the
ACBSA. Members of the Committee,
including the Chair, are appointed by
the Secretary. Members are invited to
serve on the Committee for overlapping
four-year terms.
DATES: All nominations must be
received no later than 4 p.m. EDT on
June 30, 2008, at the address listed
below.
All nominations should be
mailed or delivered to Dr. Jerry
Holmberg, Executive Secretary,
Advisory Committee on Blood Safety
and Availability; Office of Public Health
and Science; Department of Health and
Human Services; 1101 Wootton
Parkway, Suite 250; Rockville, MD
20852. Telephone: (240) 453–8803.
FOR FURTHER INFORMATION CONTACT: Dr.
Jerry Holmberg, Executive Secretary,
Advisory Committee on Blood Safety
and Availability. Contact information
for Dr. Holmberg is the same as
previously provided.
A copy of the Committee charter and
roster of the current membership can be
obtained by contacting Dr. Holmberg or
by accessing the ACBSA Web site at
https://www.hhs.gov/bloodsafety.
SUPPLEMENTARY INFORMATION: The
Advisory Committee on Blood Safety
and Availability provides advice to the
Secretary and to the Assistant Secretary
for Health. The Committee provides
advice on a range of policy issues to
include: (1) Definition of public health
parameters around safety and
availability of the blood and blood
products, (2) broad public health,
ethical and legal issues related to
transfusion and transplantation safety,
jlentini on PROD1PC65 with NOTICES
ADDRESSES:
VerDate Aug<31>2005
17:31 Apr 14, 2008
Jkt 214001
and (3) the implications for safety and
availability of various economic factors
affecting product cost and supply.
The ACBSA consists of 18 voting
members. The Committee is composed
of 12 public members, including the
Chair, and six (6) representative
members. The public members are
selected from State and local
organizations, advocacy groups,
provider organizations, academic
researchers, ethicists, private
physicians, scientists, consumer
advocates, legal organizations, and from
among communities of persons who are
frequent recipients of blood or blood
products. The six individuals who are
appointed as official representative
members are selected to serve the
interests of the blood and blood
products industry or professional
organizations associated with
transfusion or transplantation safety.
The representative members are selected
from the following groups: the AABB,
the Plasma Protein Therapeutic
Association (PPTA), one of the two
major distributors of blood on a rotating
basis, a trade organization or
manufacturer of blood, plasma, or other
tissue test kits or equipment, and a
purchaser of blood and blood products
from a major hospital organization.
All ACBSA members are authorized
to receive the prescribed per diem
allowance and reimbursement for travel
expenses that are incurred to attend
meetings and conduct Committeerelated business, in accordance with
Standard Government Travel
Regulations. Individuals who are
appointed to serve as public members
are authorized also to receive a stipend
for attending Committee meetings and
to carry out other Committee-related
business. Individuals who are appointed
to serve as representative members for a
particular interest group or industry are
not authorized to receive a stipend for
the performance of these duties.
This announcement is to solicit
nominations of qualified candidates to
fill positions on the ACBSA that are
scheduled to be vacated in the public
member category. The positions are
scheduled to be vacated on December
31, 2008.
Nominations
In accordance with the charter,
persons nominated for appointment as
members of the ACBSA should be
among authorities knowledgeable in
blood banking, transfusion medicine,
plasma therapies, transfusion and
transplantation safety, bioethics, and/or
related disciplines. Nominations should
be typewritten. The following
information should be included in the
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
package of materials submitted for each
individual being nominated for
consideration of appointment: (a) The
name, return address, daytime
telephone number and affiliation(s) of
the individual being nominated, the
basis for the individual’s nomination,
the category for which the individual is
being nominated, and a statement
bearing an original signature of the
nominated individual that, if appointed,
he or she is willing to serve as a member
of the Committee; (b) the name, return
address, and daytime telephone number
at which the nominator may be
contacted. Organizational nominators
must identify a principal contact person
in addition to the contact; and (c) a copy
of a current curriculum vitae or resume
for the nominated individual.
Individuals can nominate themselves
for consideration of appointment to the
Committee. All nominations must
include the required information.
Incomplete nominations will not be
processed for consideration. The letter
from the nominator and certification of
the nominated individual must bear
original signatures; reproduced copies
of these signatures are not acceptable.
The Department of Health and Human
Services is committed to ensuring that
women, minority groups, and physically
challenged individuals are adequately
represented on the Committee.
Nominations of qualified candidates
from these categories are encouraged.
The Department also seeks to have
geographic diversity reflected in the
composition of the Committee.
The Standards of Ethical Conduct for
Employees of the Executive Branch are
applicable to individuals who are
appointed as public members of Federal
advisory committees. Individuals
appointed to serve as public members of
Federal advisory committees are
classified as special Government
employees (SGEs). SGEs are
Government employees for purposes of
the conflict of interest laws. Therefore,
individuals appointed to serve as public
members of the ACBSA are subject to an
ethics review. The ethics review is
conducted to determine if the
individual has any interests and/or
activities in the private sector that may
conflict with performance of their
official duties as a member of the
Committee. Individuals appointed to
serve as public members of the
Committee will be required to disclose
information regarding financial
holdings, consultancies, and research
grants and/or contracts.
E:\FR\FM\15APN1.SGM
15APN1
Federal Register / Vol. 73, No. 73 / Tuesday, April 15, 2008 / Notices
Dated: April 9, 2008.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on
Blood Safety and Availability.
[FR Doc. E8–7986 Filed 4–14–08; 8:45 am]
BILLING CODE 4150–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
Statement of Organization, Functions
and Delegations of Authority
Part J (Agency for Toxic Substances
and Disease Registry) of the Statement
of Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (50 FR 25129–25130, dated
June 17, 1985, as amended most
recently at 71 FR 58396–5 8397, dated
October 3, 2006) is amended to reflect
the reorganization of the Office of the
Director, Agency for Toxic Substances
and Disease Registry.
Section J–B, Organization and
Functions, is hereby amended as
follows:
After item (9) of the functional
statement for the Office of the Director
(JAA), Agency for Toxic Substances and
Disease Registry (J), add the following:
(10) serves as primary liaison between
ATSDR and the National Center for
Health Marketing on communications
and marketing science, and its
associated research and practice.
Delete in their entirety the title and
functional statement for the Office of
Communications (JAA4).
Dated: April 2, 2008.
Joseph Henderson,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention (CDC).
[FR Doc. E8–7855 Filed 4–14–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–08AW]
jlentini on PROD1PC65 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
17:31 Apr 14, 2008
Jkt 214001
Proposed Project
Quarantine Station Illness Response
Forms—Airline, Maritime, Land/Border
Crossing—New—National Center for
Preparedness, Detection, and Control of
Infectious Diseases (NCPDCID), Centers
for Disease Control and Prevention
(CDC).
CDC proposes to collect patient-level
clinical, epidemiologic, and
demographic data from ill travelers and
their possible contacts in order to fulfill
its regulatory responsibility to prevent
the importation of communicable
diseases from foreign countries (42 CFR
Part 71) and interstate control of
communicable diseases in humans (42
CFR Part 70).
Background and Brief Description
BILLING CODE 4160–70–M
VerDate Aug<31>2005
Prevention (CDC) will publish periodic
summaries of proposed projects.
Alternatively, to obtain a copy of the
data collection plans and instrument,
call 404–639–5960 and send comments
to Maryam I. Daneshvar, CDC Reports
Clearance Officer, 1600 Clifton Road,
NE., MS-D74, Atlanta, Georgia 30333;
comments may also be sent by e-mail to
omb@cdc.gov.
Comments are invited on (a) whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarify of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of information technology. Written
comments should be received within 60
days of this notice.
Section 361 of the Public Health
Service (PHS) Act (42 U.S.C. 264)
authorizes the Secretary of Health and
Human Services to make and enforce
regulations necessary to prevent the
introduction, transmission or spread of
communicable diseases from foreign
countries into the United States. The
regulations that implement this law, 42
CFR Parts 70 and 71, authorize
quarantine officers and other personnel
to inspect and undertake necessary
control measures with respect to
conveyances (e.g., airplanes, cruise
ships, trucks, etc.), persons, and
shipments of animals and etiologic
agents in order to protect the public
health. The regulations also require
conveyances to immediately report an
‘‘ill person’’ or any death on board to
the Quarantine Station prior to arrival in
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
20293
the United States. An ‘‘ill person’’ is
defined in statute by:
—Fever (≥100 °F or 38 °C) persisting ≥48
hours
—Fever (≥100 °F or 38 °C) AND rash,
glandular swelling, or jaundice
—Diarrhea (≥3 stools in 24 hours or
greater than normal amount)
The SARS situation and concern
about pandemic influenza and other
communicable diseases have prompted
CDC Quarantine Stations to recommend
that all illnesses be reported prior to
arrival.
CDC Quarantine Stations are currently
located at 20 international U.S. Ports of
Entry. When a suspected illness is
reported to the Quarantine Station,
officers promptly respond to this report
by meeting the incoming conveyance
(when possible), collecting information
and evaluating the patient(s), and
determining whether an ill person can
safely be admitted into the U.S. If
Quarantine Station staff are unable to
meet the conveyance, the crew or
medical staff of the conveyance are
trained to complete the required
documentation and forward it (using a
secure system) to the Quarantine Station
for review and follow-up.
To perform these tasks in a
streamlined manner and ensure that all
relevant information is collected in the
most efficient and timely manner
possible, Quarantine Stations use a
number of forms—the Airline Screening
and Illness Response Form, the Ship
Illness/Death Reporting Form, and the
Land/Border Crossing Form—to collect
data on passengers with suspected
illness and other travelers/crew who
may have been exposed to an illness.
These forms are also used to respond to
a report of a death aboard a conveyance.
The purpose of all three forms is the
same: to collect information that helps
quarantine officials detect and respond
to potential public health
communicable disease threats. All three
forms collect the following categories of
information: Demographics and mode of
transportation, clinical and medical
history, and any other relevant facts
(e.g., travel history, traveling
companions, etc.). As part of this
documentation, quarantine public
health officers look for specific signs
and symptoms common to the nine
quarantinable diseases (Pandemic
influenza; SARS; Cholera; Plague;
Diphtheria; Infectious Tuberculosis;
Smallpox; Yellow fever; and Viral
Hemorrhagic Fevers), as well as most
communicable diseases in general.
These signs and symptoms include
fever, difficulty breathing, shortness of
breath, cough, diarrhea, jaundice, or
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 73, Number 73 (Tuesday, April 15, 2008)]
[Notices]
[Pages 20292-20293]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-7986]
[[Page 20292]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the Advisory
Committee on Blood Safety and Availability
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of Public Health and Science (OPHS) is seeking
nominations of qualified individuals to be considered for appointment
as members of the Advisory Committee on Blood Safety and Availability
(ACBSA). ACBSA is a Federal advisory committee in the Department of
Health and Human Services. Management support for the activities of
this Committee is the responsibility of the OPHS.
The qualified individuals will be nominated to the Secretary of
Health and Human Services for consideration of appointment as members
of the ACBSA. Members of the Committee, including the Chair, are
appointed by the Secretary. Members are invited to serve on the
Committee for overlapping four-year terms.
DATES: All nominations must be received no later than 4 p.m. EDT on
June 30, 2008, at the address listed below.
ADDRESSES: All nominations should be mailed or delivered to Dr. Jerry
Holmberg, Executive Secretary, Advisory Committee on Blood Safety and
Availability; Office of Public Health and Science; Department of Health
and Human Services; 1101 Wootton Parkway, Suite 250; Rockville, MD
20852. Telephone: (240) 453-8803.
FOR FURTHER INFORMATION CONTACT: Dr. Jerry Holmberg, Executive
Secretary, Advisory Committee on Blood Safety and Availability. Contact
information for Dr. Holmberg is the same as previously provided.
A copy of the Committee charter and roster of the current
membership can be obtained by contacting Dr. Holmberg or by accessing
the ACBSA Web site at https://www.hhs.gov/bloodsafety.
SUPPLEMENTARY INFORMATION: The Advisory Committee on Blood Safety and
Availability provides advice to the Secretary and to the Assistant
Secretary for Health. The Committee provides advice on a range of
policy issues to include: (1) Definition of public health parameters
around safety and availability of the blood and blood products, (2)
broad public health, ethical and legal issues related to transfusion
and transplantation safety, and (3) the implications for safety and
availability of various economic factors affecting product cost and
supply.
The ACBSA consists of 18 voting members. The Committee is composed
of 12 public members, including the Chair, and six (6) representative
members. The public members are selected from State and local
organizations, advocacy groups, provider organizations, academic
researchers, ethicists, private physicians, scientists, consumer
advocates, legal organizations, and from among communities of persons
who are frequent recipients of blood or blood products. The six
individuals who are appointed as official representative members are
selected to serve the interests of the blood and blood products
industry or professional organizations associated with transfusion or
transplantation safety. The representative members are selected from
the following groups: the AABB, the Plasma Protein Therapeutic
Association (PPTA), one of the two major distributors of blood on a
rotating basis, a trade organization or manufacturer of blood, plasma,
or other tissue test kits or equipment, and a purchaser of blood and
blood products from a major hospital organization.
All ACBSA members are authorized to receive the prescribed per diem
allowance and reimbursement for travel expenses that are incurred to
attend meetings and conduct Committee-related business, in accordance
with Standard Government Travel Regulations. Individuals who are
appointed to serve as public members are authorized also to receive a
stipend for attending Committee meetings and to carry out other
Committee-related business. Individuals who are appointed to serve as
representative members for a particular interest group or industry are
not authorized to receive a stipend for the performance of these
duties.
This announcement is to solicit nominations of qualified candidates
to fill positions on the ACBSA that are scheduled to be vacated in the
public member category. The positions are scheduled to be vacated on
December 31, 2008.
Nominations
In accordance with the charter, persons nominated for appointment
as members of the ACBSA should be among authorities knowledgeable in
blood banking, transfusion medicine, plasma therapies, transfusion and
transplantation safety, bioethics, and/or related disciplines.
Nominations should be typewritten. The following information should be
included in the package of materials submitted for each individual
being nominated for consideration of appointment: (a) The name, return
address, daytime telephone number and affiliation(s) of the individual
being nominated, the basis for the individual's nomination, the
category for which the individual is being nominated, and a statement
bearing an original signature of the nominated individual that, if
appointed, he or she is willing to serve as a member of the Committee;
(b) the name, return address, and daytime telephone number at which the
nominator may be contacted. Organizational nominators must identify a
principal contact person in addition to the contact; and (c) a copy of
a current curriculum vitae or resume for the nominated individual.
Individuals can nominate themselves for consideration of
appointment to the Committee. All nominations must include the required
information. Incomplete nominations will not be processed for
consideration. The letter from the nominator and certification of the
nominated individual must bear original signatures; reproduced copies
of these signatures are not acceptable.
The Department of Health and Human Services is committed to
ensuring that women, minority groups, and physically challenged
individuals are adequately represented on the Committee. Nominations of
qualified candidates from these categories are encouraged. The
Department also seeks to have geographic diversity reflected in the
composition of the Committee.
The Standards of Ethical Conduct for Employees of the Executive
Branch are applicable to individuals who are appointed as public
members of Federal advisory committees. Individuals appointed to serve
as public members of Federal advisory committees are classified as
special Government employees (SGEs). SGEs are Government employees for
purposes of the conflict of interest laws. Therefore, individuals
appointed to serve as public members of the ACBSA are subject to an
ethics review. The ethics review is conducted to determine if the
individual has any interests and/or activities in the private sector
that may conflict with performance of their official duties as a member
of the Committee. Individuals appointed to serve as public members of
the Committee will be required to disclose information regarding
financial holdings, consultancies, and research grants and/or
contracts.
[[Page 20293]]
Dated: April 9, 2008.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on Blood Safety and
Availability.
[FR Doc. E8-7986 Filed 4-14-08; 8:45 am]
BILLING CODE 4150-41-P
